Issue link: http://read.dmtmag.com/i/59015
Latest clinical evidence and injection recommendations advocate shorter needles1-6 The BD Nano, "World's Smallest Pen Needle" 4mm x 32g BD Insulin Syringes with the BD Ultra-Fine™ 6mm needle Clinically proven as effective for patients of all sizes* Allows for single handed "no pinch" technique Reduces the risk of an intramuscular injection Compatible with all diabetes pens sold in the U.S. Expand your diabetes products offering and increase your profits with the BD 90ct* box insulin syringes and pen needles program. Exclusively for HME/DME/Medical Benefit and Mail Order Rx providers. All buying accounts must sign a BD joinder agreement. References: 1. Schwartz S, Hassman D Shelmet J, et al. A multcenter, open-label, randomized, two-period crossowver trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6mm needle versus a 29 gauge x 12.7mm needle in obese patients with diabetes mellitus. Clin Ther. 2004;26(10):1663-1678. 2. Kreugel G, Keers JC, Kerstens MN, Wolffenbuttel BHR. Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes [published online ahead of print April 10, 2001]. Diabetes Technol Ther. 2011;13(7)737-741. doi:10.1089/dia.2011.0010.3. Hirsch LJ, Gibney MA, Albanese J, et al. Comparative glycemic control safety and patient ratings for a new 4mm x 32g insulin pen needle in adults with diabetes. Curr Med Res Opin. 2010;26(6)1531-1541. 4. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Cur Med Res Opin. 2010;26(6):1519-1530. 5. Data on file. 6. Frid A, Hirsch L, Gaspar R, et al; Scientific Advisory Board for the Third Injection Technique Workshop. New injection recommendations for patients with diabetes mellitus. Diabetes Metab. 2010;36(suppl 2):59. BD, BD Logo, and BD Ultra-Fine are trademarks of Becton, Dickinson and Company. ®2012 BD. 80% of patients prefer it to their current insulin syringe needle† Equivalent to longer needles Less intimidating for patients Reduces the risk of a painful intramuscular injection 4 1-4* 5 11800 28th St. N St. Petersburg, FL 33716 727-572-4288 Fax: 800-571-9444 www.ddpmedical.com NEW!